Cargando…

Adjuvant Effects of a New Saponin Analog VSA-1 on Enhancing Homologous and Heterosubtypic Protection by Influenza Virus Vaccination

Adjuvants can increase the magnitude and durability of the immune response generated by the vaccine antigen. Aluminum salts (Alum) remain the main adjuvant licensed for human use. A few new adjuvants have been licensed for use in human vaccines since the 1990s. QS-21, a mixture of saponin compounds,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatnagar, Noopur, Kim, Ki-Hye, Subbiah, Jeeva, Park, Bo Ryoung, Wang, Pengfei, Gill, Harvinder Singh, Wang, Bao-Zhong, Kang, Sang-Moo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501088/ https://www.ncbi.nlm.nih.gov/pubmed/36146461 http://dx.doi.org/10.3390/vaccines10091383

Ejemplares similares

Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
por: Kim, Hyunjung, et al.
Publicado: (2022)

Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
por: Bhatnagar, Noopur, et al.
Publicado: (2023)

Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
por: Park, Bo Ryoung, et al.
Publicado: (2023)

Immunogenicity and Neutralizing Activity Comparison of SARS-CoV-2 Spike Full-Length and Subunit Domain Proteins in Young Adult and Old-Aged Mice
por: Kim, Ki-Hye, et al.
Publicado: (2021)

Foreground Radio Sources And The Vsa
por: Grainge, K
Publicado: (2000)

Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle
por: Kim, Ki-Hye, et al.
Publicado: (2022)

A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine
por: Subbiah, Jeeva, et al.
Publicado: (2022)

Natural and Synthetic Saponins as Vaccine Adjuvants
por: Wang, Pengfei
Publicado: (2021)

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
por: Park, Bo Ryoung, et al.
Publicado: (2021)

Thermostable H1 hemagglutinin stem with M2e epitopes provides broad cross-protection against group1 and 2 influenza A viruses
por: Subbbiah, Jeeva, et al.
Publicado: (2022)

Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection
por: Wang, Bao-Zhong, et al.
Publicado: (2010)

Cascade Control of Antagonistic VSA—An Engineering Control Approach to a Bioinspired Robot Actuator
por: Lukić, Branko, et al.
Publicado: (2019)

An Update on mRNA-Based Viral Vaccines
por: Jeeva, Subbiah, et al.
Publicado: (2021)

Characterization and Comparative Analysis of the Staphylococcus aureus Genomic Island vSaβ: an In Silico Approach
por: Kläui, Anita J., et al.
Publicado: (2019)

Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus
por: Jung, Yu-Jin, et al.
Publicado: (2020)

VSA-3000: A Quantitative Vibration Sensation Testing Device for Patients With Central Nervous System Injury
por: Gao, Mingming, et al.
Publicado: (2020)

Modeling, Control, and Numerical Simulations of a Novel Binary-Controlled Variable Stiffness Actuator (BcVSA)
por: Hussain, Irfan, et al.
Publicado: (2018)

Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome
por: Shin, Chong-Hyun, et al.
Publicado: (2021)

Potentials of saponins-based adjuvants for nasal vaccines
por: Chen, Kai, et al.
Publicado: (2023)

A “NEW” way to look at an “old” test: Transforming the void spot assay (VSA) into a diagnostic tool
por: Dalghi, Marianela G.
Publicado: (2021)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza
por: Wang, Jiong, et al.
Publicado: (2015)

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
por: Magini, Diletta, et al.
Publicado: (2016)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Staphylococcal Enterotoxin Gene Cluster: Prediction of Enterotoxin (SEG and SEI) Production and of the Source of Food Poisoning on the Basis of vSaβ Typing
por: Schwendimann, L., et al.
Publicado: (2021)

Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice
por: Wang, Li, et al.
Publicado: (2013)

Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice
por: Luo, Yuan, et al.
Publicado: (2018)

Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant
por: Luo, Jian, et al.
Publicado: (2019)

Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs
por: Giunchetti, Rodolfo Cordeiro, et al.
Publicado: (2007)

Exploring the possible use of saponin adjuvants in COVID-19 vaccine
por: Sharma, Rinku, et al.
Publicado: (2020)

Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice
por: Wang, Mingxing, et al.
Publicado: (2018)

Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection
por: Jung, Yu-Jin, et al.
Publicado: (2017)

Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti–Influenza A Antibodies
por: Sui, Jianhua, et al.
Publicado: (2011)

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)

Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response
por: Carascal, Mark B., et al.
Publicado: (2022)

Development of a minimal saponin vaccine adjuvant based on QS-21
por: Fernández-Tejada, Alberto, et al.
Publicado: (2014)

Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice
por: Vassilieva, Elena V., et al.
Publicado: (2019)

Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats
por: Straight, Timothy M, et al.
Publicado: (2008)

Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza
por: Lynch, Garry W, et al.
Publicado: (2009)

Adaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected Mallards
por: Segovia, Karen M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_openk9h5pnhq6imb6aao6pge4r